Form D · Biotechnology

Predicine Holdings Ltd

Hayward, CA · CIK 0001806237

Offering snapshot reported Sep 30, 2020 · SEC filing

Reported sold
$12.7M
Offering amount: $12.7M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 18, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 30, 2020Initial$12,686,879No comparison6SEC filing
Apr 6, 2020Initial$8,526,497No comparison4SEC filing
Apr 6, 2020Initial$5,000,000No comparison4SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-376681

Source: Form D, filed Sep 30, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Haipeng Cheng Director
N/A Cia Asia Corporate Services Limited Of Start Chambers Executive
Pan Du Director
Shidong Jia Director, Executive
Yuexing Su Director
Qian Wang Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3555 Arden Road
Hayward, CA, 94545